CION Ameerpet
Survivorship & Late Effects
Late-Effects Surveillance for Childhood Cancer Survivors — What’s Checked, From When, and For How Long
Follow-up does not end when the last session does. Late-effects surveillance is a planned, lifelong schedule of checks — growth, hormones, heart, hearing, learning, fertility and second-cancer screening — matched to the exact treatment your child received. Here is what is monitored, when it starts, and how long it continues.
Medically reviewed by Dr. Venkata Sushma P, Radiation Oncologist, MBBS · MD (Radiation Oncology) · Last reviewed August 2026
- The schedule follows the treatment, not the diagnosis — which fields were treated, at what dose, which chemotherapy was given and at what age — that is what decides the checks, so two children with the same cancer can have different plans.
- Growth, puberty and fertility are tracked, not assumed — height and growth velocity at every visit, puberty timing through the teenage years, and a fertility conversation offered at an age the young person can take part in.
- School and learning are part of the review — attention, memory, reading speed and classroom performance are reviewed alongside the blood tests, especially after brain-directed treatment.
- It carries on into adult care — surveillance does not stop at eighteen — a written treatment summary hands the schedule over to the adult team so nothing quietly lapses.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The direct answer
What Is Monitored in Childhood Cancer Survivor Follow-Up?
Follow-up checks the organs and systems the treatment could have affected. In practice that means growth and height, puberty and hormone levels, thyroid function, heart and lung function, hearing and vision, kidney function, bone health, learning and school performance, fertility, and screening for a second cancer in any irradiated area.
No survivor needs every check on that list. The schedule is built from the treatment your child actually received — which fields were treated, at what total dose, which chemotherapy was given, and how old your child was at the time. That is why two children with the same diagnosis can walk out with different follow-up plans, and why a general survivorship checklist off the internet is not the same thing as your child’s own schedule.
Growth & hormones
Height, puberty, thyroid
Height, growth velocity and puberty timing at every visit, with hormone blood tests on a set schedule after brain, neck or spinal fields.
Heart & lungs
Function, not symptoms alone
Heart function and breathing are reviewed where the chest was treated, or where a chemotherapy regimen known to affect the heart was given.
Hearing, vision & nerves
Tested, not assumed
Hearing tests, eye checks and any balance or nerve symptoms, particularly after head, brain-directed or ear-adjacent treatment.
Learning & school
Attention, memory, pace
Reading speed, memory, attention and classroom performance are reviewed with parents, and formally assessed where a teacher or parent flags a change.
Fertility & sexual health
Raised at the right age
Puberty progress is tracked through the teenage years, and an honest fertility conversation is offered when the young person can take part in it.
Second-cancer screening
Of irradiated areas
Planned screening of any area that received radiation, on a schedule the treating team sets in line with NCCN survivorship guidance.
Your child’s radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates the treatment plan, the paediatric oncology team and your child’s care throughout — including the surveillance schedule that follows treatment.
The starting point
When Does Late-Effects Surveillance Start?
It starts immediately. The first surveillance visit is usually within one to three months of the final treatment session, and the schedule is written before your child leaves active treatment. Height, weight, blood counts and a general examination begin at that first visit; organ-specific tests are added at set intervals afterwards.
Ask for two documents at that handover visit. The first is a treatment summary: the fields treated, the total radiation dose, the chemotherapy given and the dates. The second is the surveillance schedule itself — which check is due, and when. Families who leave with both spend far less of the next decade reconstructing what happened from memory.
Several of the earliest tests exist mainly as a baseline. A hearing test or a heart scan done soon after treatment may be entirely normal, and that is precisely the point: it gives the team a starting line to compare against years later. A normal baseline is a useful result, not a wasted appointment.
Did you know?
Some late effects of childhood cancer treatment appear years, or even decades, after the last session — which is why NCCN survivorship guidance recommends a written treatment summary and a risk-based follow-up plan that carries into adult care, rather than follow-up that stops at a fixed number of years.
The honest answer
How Long Does Follow-Up Continue?
For life, at a frequency that falls steadily over time. Visits are typically every three to four months in the first two years, every six months out to around five years, then yearly. After that, most survivors move to an annual risk-based review that continues into adult care. The schedule thins out; it does not end.
That surprises many families, because the first years are the ones everyone braces for. But the effects being watched for later are different ones. Hormone changes, heart and lung effects, hearing loss, bone health and second cancers in an irradiated area are all things that can surface long after the treatment room is a memory, which is why an annual review keeps earning its place.
For teenagers and young adults, this is also the point where ownership shifts. Somewhere between sixteen and nineteen, care hands over from the paediatric team to an adult one. The young person who keeps their own copy of the treatment summary, knows which checks are due and can explain their history to a new doctor is the one whose surveillance does not quietly lapse.
CION Cancer Clinics coordinates this follow-up alongside the paediatric oncology team and the NABH-accredited partner centre where radiotherapy was delivered, so the plan stays in one place rather than scattered across letters.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Want Your Child’s Surveillance Schedule Explained?
Talk to a radiation oncologist about which late-effect checks follow your child’s specific treatment, in plain language.
Stage by stage
What Happens at Each Stage of Follow-Up?
A typical shape for the years after treatment. Your child’s own schedule may be tighter or lighter depending on what was treated — use this to know what to ask for, not as a substitute for the written plan.
1
First 1–3 months after treatment ends
The handover visit. Your child gets a written treatment summary and a surveillance schedule, plus baseline height, weight, blood counts and any baseline organ tests the plan calls for.
2
Months 3–24 — every 3 to 4 months
Growth measurements, blood counts and a symptom review at every visit, with organ-specific tests slotted in as they fall due. Imaging happens only where the plan calls for it. If a younger child needs a brief sedated scan, the anaesthetic team explains what that involves beforehand.
3
Years 2–5 — every 6 months
Hormone panels, thyroid checks, heart and hearing tests keyed to the fields treated, puberty tracking, and a school and learning review with the parents in the room.
4
Year 5 onwards — yearly, risk-based
An annual review built around the treatment received rather than the diagnosis. Screening of irradiated areas for a second cancer begins on a schedule the team sets, and bone health and fertility questions move up the agenda.
5
Age 16–19 — transition to adult care
A planned handover to an adult team, with the treatment summary carried across so surveillance continues without guesswork. The young adult is brought into the conversation directly, including on fertility.
By treatment received, not by diagnosis
Which Checks Apply, Based on What Treatment Was Given?
A general map, not a personal plan. Find the rows that match your child’s treatment summary, then confirm the exact intervals with the treating team.
| Treatment received | What can show up later | What is monitored, and roughly how often |
|---|---|---|
| Brain or skull-base radiation | Growth hormone and other pituitary hormone changes; memory, attention and processing speed | Height and growth velocity every visit; hormone bloods every 6–12 months; a learning and school review yearly |
| Neck or thyroid-area radiation | An underactive thyroid; thyroid nodules | Thyroid blood tests every 6–12 months; neck examination at each visit |
| Chest radiation | Heart and lung effects; breast tissue inside the treated field | Heart and lung review yearly; breast screening from an age the team sets, per NCCN survivorship guidance |
| Abdominal or pelvic radiation | Kidney and bowel effects; reduced fertility | Kidney blood tests and a bowel symptom review yearly; puberty tracking and a fertility discussion at the right age |
| Spinal radiation | Reduced sitting height; posture and spine changes | Sitting and standing height at every visit; spine and posture review yearly |
| Total body irradiation before a transplant | Several hormone systems together, plus eye, bone and fertility effects | A comprehensive endocrine panel, eye checks and bone health review, coordinated with transplant survivorship care |
| Chemotherapy known to affect the heart or hearing | Reduced heart function; hearing loss, often in the higher frequencies first | Heart scan and hearing test on the interval the treating team sets, continuing into adult follow-up |
Radiotherapy for children is delivered at NABH-accredited partner centres; CION Cancer Clinics coordinates the plan, the team and the follow-up that comes after it.
Make each visit count
What Should Families Bring to Every Follow-Up Visit?
Follow-up appointments are short. Arriving with these five things turns a routine check into a useful one.
- The written treatment summary — fields treated, total dose, chemotherapy given and dates. If you do not have one, ask for it in writing at the next visit.
- The growth chart — height and weight plotted over time tells the team more in ten seconds than a single measurement can.
- School reports and teacher feedback — particularly anything noted about attention, reading, fatigue or falling behind.
- A written list of questions — including the awkward ones about puberty and fertility, which are far easier to ask from a list.
- Any new symptom since the last visit — hearing, breathing, tiredness, periods, mood — even if it seems unrelated to cancer.
Real families, real experiences
Hear From Families Who Asked the Same Questions
Every child’s treatment history is different, and so is the follow-up that comes with it — talk to our team about yours.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Childhood cancer survivor follow-up — questions parents and young adults ask
What is monitored in childhood cancer survivor follow-up?
Follow-up checks the organs and systems the treatment could have affected. That usually means growth and height, puberty timing and hormone levels, thyroid function, heart and lung function, hearing and vision, kidney function, bone health, learning and school performance, fertility, and screening for a second cancer in any area that received radiation. Not every survivor needs every check. The list is built from the treatment your child actually received — which fields were treated, which chemotherapy was given, at what dose and at what age — so two children with the same diagnosis can end up with quite different schedules. Ask your child’s team for the schedule in writing, so you know what is due and when.
When does late-effects surveillance start after treatment ends?
It starts straight away. The first surveillance visit is usually within one to three months of the last treatment session, and the schedule itself is written before your child leaves active treatment. Some checks begin at that first visit — height, weight, blood counts and a general examination. Others are added at set intervals, because they are looking for changes that take time to appear, such as hormone levels after brain-directed radiation or heart function after treatment known to affect the heart. Several early tests exist mainly as a baseline. They give the team something to compare against years later, which is why they matter even when the result is completely normal.
How long does a childhood cancer survivor need follow-up?
For life, but not at the same intensity throughout. Visits are typically every three to four months for the first two years, every six months up to around five years, and yearly after that. From roughly five years on, most survivors move to an annual risk-based review that continues into adult care. Follow-up does not simply stop because some late effects appear years or even decades after treatment — hormone changes, heart effects, fertility questions and second cancers in irradiated areas among them. NCCN survivorship guidance recommends a written treatment summary and a risk-based plan carried into adult care, rather than follow-up that ends at a fixed number of years.
Who looks after follow-up once my child becomes an adult?
Care transfers from the paediatric oncology team to an adult team, usually somewhere between the ages of sixteen and nineteen, and the handover is planned rather than sudden. The single most important thing to carry across is the written treatment summary: the total radiation dose, the fields treated, the chemotherapy given and the dates. An adult clinician who has that document can continue the right surveillance without guessing. Young adults are also encouraged to take ownership of the schedule during this period — keeping their own copy of the summary, knowing which checks are due, and being able to explain their treatment history to any new doctor they meet.
Does regular surveillance mean my child’s cancer is expected to come back?
No. Late-effects surveillance and recurrence monitoring are two different things running side by side. Recurrence checks are usually most intensive in the first two to three years and then ease off. Late-effects surveillance does the opposite — it becomes more relevant with time, because it is looking for slow changes to growth, hormones, organs and hearing. A schedule that continues for years is a sign that the plan is thorough, not a sign that something is expected to go wrong. If you are unsure which of the two a particular test belongs to, ask directly — the team can tell you what each check is looking for.
When should fertility be discussed after childhood cancer treatment?
It should be raised twice: once before treatment wherever that is possible, and again as your child approaches or moves through puberty. Fertility can be affected by radiation to the pelvis or the whole body and by some chemotherapy regimens, and the degree varies widely from child to child — which is why it is monitored over time rather than predicted at the start. In practice, puberty timing and hormone levels are tracked through the teenage years, and a fertility discussion is offered at an age when the young person can take part in it. Teenagers and young adults are entitled to that conversation directly, with or without a parent in the room.